8B75 image
Entry Detail
PDB ID:
8B75
Title:
CRYSTAL STRUCTURE OF HUMAN SOLUBLE ADENYLYL CYCLASE IN COMPLEX WITH THE INHIBITOR TDI-011861
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2022-09-28
Release Date:
2023-03-29
Method Details:
Experimental Method:
Resolution:
1.82 Å
R-Value Free:
0.24
R-Value Work:
0.20
Space Group:
P 63
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Adenylate cyclase type 10
Chain IDs:A
Chain Length:475
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
CME A CYS modified residue
Ligand Molecules
Primary Citation
Design, Synthesis, and Pharmacological Evaluation of Second-Generation Soluble Adenylyl Cyclase (sAC, ADCY10) Inhibitors with Slow Dissociation Rates.
J.Med.Chem. 65 15208 15226 (2022)
PMID: 36346696 DOI: 10.1021/acs.jmedchem.2c01133

Abstact

Soluble adenylyl cyclase (sAC: ADCY10) is an enzyme involved in intracellular signaling. Inhibition of sAC has potential therapeutic utility in a number of areas. For example, sAC is integral to successful male fertility: sAC activation is required for sperm motility and ability to undergo the acrosome reaction, two processes central to oocyte fertilization. Pharmacologic evaluation of existing sAC inhibitors for utility as on-demand, nonhormonal male contraceptives suggested that both high intrinsic potency, fast on and slow dissociation rates are essential design elements for successful male contraceptive applications. During the course of the medicinal chemistry campaign described here, we identified sAC inhibitors that fulfill these criteria and are suitable for in vivo evaluation of diverse sAC pharmacology.

Legend

Protein

Chemical

Disease

Primary Citation of related structures